Nexgen Energy Ltd. Common Shares vs Health Care Select Sector SPDR Fund — how do they compare? Nexgen Energy Ltd. Common Shares trades at $8.77 (market cap $6.04B), while Health Care Select Sector SPDR Fund trades at $168.16 (market cap $43.11B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 7.1× Nexgen Energy Ltd. Common Shares's market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Nexgen Energy Ltd. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nexgen Energy Ltd. Common Shares for 0 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| NXE | XLV | |
|---|---|---|
Market Cap | $6.04B | $43.11B |
Volume | 4,194,158 | 8,870,090 |
Sector | Energy | — |
52-Week High | $13.92 | $175.68 |
52-Week Low | $7.56 | $141.95 |
Typical Hold Time | 0 Days | 100 Days |
Enterprise Value | $5.79B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XLV trades at $168.81, up 1.03% with a bullish technical signal from moving averages. The healthcare ETF shows strength with 61 diversified holdings and a low 0.08% expense ratio. Recent news highlights its defensive characteristics during market volatility and potential benefits from rising interest rates. Technical indicators show support at $168 with resistance at $170, while oscillators remain neutral.
XLV offers defensive exposure to healthcare with cost efficiency, though concentration in S&P 500 stocks limits global diversification. Political uncertainty and sector-specific risks like FDA approvals present challenges, but the ETF's broad diversification and historical performance during rate hikes support a constructive outlook for long-term investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
NexGen Energy develops uranium projects in Canada. Its main asset is the Rook I Project in Saskatchewan, which includes the Arrow uranium deposit.
Read more on NXE →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →